Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Holders of 5% or more of PLRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pliant Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Tang Capital Management LLC | 13D | 9.60%5.86M shares | New | Mar 10, 20251 filing | Mar 10, 2025 | SEC |
| Woodline Partners LP | 13G | 7.30%4.50M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Point72 Asset Management, L.P. | 13G | 6.70%4.09M shares | New | Sep 4, 20251 filing | Sep 4, 2025 | SEC |
| Morgan Stanley | 13G | 6.10%3.74M shares | New | Aug 6, 20251 filing | Aug 6, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on Pliant Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:17 PM ET | Woodline Partners LP | 13G | 7.30%4.50M shares | New | Sep 30, 2025 | SEC |
| Nov 14, 20258:22 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 0.00%0 shares | −6.43 ppfrom 6.43%Below 5% | Sep 30, 2025 | SEC |
| Sep 4, 20255:13 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 6.70%4.09M shares | New | Aug 27, 2025 | SEC |
| Aug 14, 20258:49 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 6.43%3.95M shares | – | Jun 30, 2025 | SEC |
| Aug 6, 20252:12 PM ET | Morgan Stanley | 13G | 6.10%3.74M shares | New | Jun 30, 2025 | SEC |
| Jul 29, 20252:22 PM ET | Vanguard Group Inc | 13G/A | 4.89%3.00M shares | –Below 5% | Jun 30, 2025 | SEC |
| Jul 17, 20258:12 PM ET | BlackRock, Inc. | 13G/A | 3.40%2.10M shares | –Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:39 PM ET | Paradigm Biocapital Advisors LPand 3 others | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2025 | SEC |
| May 14, 202510:45 AM ET | Price T Rowe Associates Inc | 13G/A | 0.10%87.7K shares | –Below 5% | Mar 31, 2025 | SEC |
| Mar 10, 20255:24 PM ET | Tang Capital Management LLCand 6 others | 13D | 9.60%5.86M shares | New | Mar 3, 2025 | SEC |
| Mar 7, 202510:01 AM ET | FMR LLCand 1 other | 13G/A | 0.20%132.0K shares | –Below 5% | Feb 28, 2025 | SEC |
| Feb 14, 20258:01 PM ET | Redmile Group, LLCand 1 other | 13G/A | 4.80%2.90M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Pliant Therapeutics, Inc. shares.
No Form 144 notices for Pliant Therapeutics, Inc. are on file.